AmacaThera
PrivateLast Round
Series A
Extension
Nov 28, 2023
Total Funding Raised
$14.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AmacaThera is a biotechnology company that develops an injectable hydrogel platform for localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AmacaThera Comparables
Compare AmacaThera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allay Therapeutics | 88% | |
| AiViva BioPharma | 84% | |
| InSitu Biologics, Inc. | 83% |
AmacaThera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 28, 2023 | ||||
| Series A | Feb 22, 2021 | ||||
| Seed | Oct 3, 2019 |
AmacaThera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Grey Sky Venture Partners | Seed |
| Inveready | Series A, Series A Extension |
| MaRS Discovery District | Series A, Series A Extension |
| BDC Capital | Series A, Series A Extension |
| Viva BioInnovator | Series A |
| Viva Biotech | Seed |
| Lumira Ventures | Seed, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 2315% MoM, reaching 3.7K.
- Jun 26, 2026
Grew 27% QoQ from 15 to 19 employees.
AmacaThera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AmacaThera's valuation, stock price, and market status.
Is AmacaThera a public or private company?
AmacaThera is a private company.
What is the current stock price of AmacaThera?
AmacaThera is a private company with no public stock price. No recent secondary market data is available.
How much is AmacaThera worth (valuation)?
Valuation information for AmacaThera is not publicly available.
Can I buy AmacaThera stock?
AmacaThera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AmacaThera's last funding round?
AmacaThera's most recent funding round was Series A Extension on November 28, 2023.
Who are the main investors in AmacaThera?
Key investors in AmacaThera include Viva Biotech, Lumira Ventures, Sprout BioVentures.
Will AmacaThera IPO soon?
No public IPO plans have been announced for AmacaThera.
How can I track AmacaThera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AmacaThera's secondary market activity and sign up for updates.